By Roxanne Nelson, RN, BSN
Liver transplant is an effective therapy for patients with primary liver cancer, and outcomes after transplantation are often superior to surgical resection. But the pool of potential patients is increasing, as transplantation is now emerging as an attractive option for select patients with nonresectable colorectal cancer (CRC) liver metastases, as well as those with intrahepatic cholangiocarcinoma (CCA).
Experts in the field highlighted some of the current challenges and opportunities in transplant oncology during a special session at the 2023 Gastrointestinal Cancers Symposium.
Read more in Medscape.